Document Report Card

Basic Information

ID: ALA4706643

Journal: J Med Chem

Title: Potent and Specific Inhibition of NTCP-Mediated HBV/HDV Infection and Substrate Transporting by a Novel, Oral-Available Cyclosporine A Analogue.

Authors: Liu Y,Ruan H,Li Y,Sun G,Liu X,He W,Mao F,He M,Yan L,Zhong G,Yan H,Li W,Zhang Z

Abstract: Analogues of the natural product cyclosporine A (CsA) were developed and assessed as antivirals against infection of hepatitis B virus (HBV) and its satellite hepatitis D virus (HDV). An analogue termed 27A exhibits potent inhibition of HBV/HDV infection by specifically blocking viral engagement to its cellular receptor NTCP, while it lacks immunosuppressive activity found in natural CsA. Intraperitoneal injection or oral intake of 27A protects HDV-susceptible mouse model from HDV infection. 27A serves as a promising lead for the development of novel anti-HDV/HBV agents.

CiteXplore: 33369415

DOI: 10.1021/acs.jmedchem.0c01484